Chiron Real Estate (XRN) Q1 2026 earnings summary
Event summary combining transcript, slides, and related documents.
Q1 2026 earnings summary
13 May, 2026Executive summary
Initiated a strategic repositioning to focus on senior housing operating properties, now representing over 25% of asset value, with a goal to become a leading capital provider for essential healthcare operators.
Announced agreements to acquire three Class-A/luxury senior housing communities in the Washington, D.C. metro area for $425 million, targeting high-quality, supply-constrained markets and expected to deliver double-digit unlevered IRRs.
Secured a $100 million strategic/convertible preferred equity investment from Maewyn Capital Partners, with board representation to enhance capital allocation discipline.
Reduced annual dividend by approximately 36% to $1.92 per share or $0.16 per month, freeing $15 million annually to support growth and capital retention.
No property acquisitions or dispositions completed in Q1 2026; investment activity focused on a new joint venture for an active adult community.
Financial highlights
Nareit defined FFO per share and unit was $0.97 for the quarter; Core FFO was $1.11 per share and unit, unchanged year-over-year.
Net (loss) income attributable to common stockholders was $(0.06) per share, compared to $0.16 per share in Q1 2025; total revenue for Q1 2026 increased 10% year-over-year to $38.1 million.
Same-store cash NOI increased 3.2% year-over-year.
Net debt to Adjusted EBITDA improved to 6.6x, down 0.4x year-over-year.
FAD for the quarter was $13.3 million, nearly unchanged year-over-year.
Outlook and guidance
Withdrew 2026 earnings guidance due to active portfolio transition and capital redeployment; focus shifted to long-term value creation and capital allocation objectives.
Long-term earnings growth target of 6% expected to be reached by the second half of 2028, with stabilization beginning in 2027-2028.
Latest events from Chiron Real Estate
- Strategic acquisitions and a diversified portfolio drive growth and support a well-covered dividend.XRN
Investor presentation7 May 2026 - Disciplined healthcare real estate strategy drives growth, high occupancy, and stable dividends.XRN
Investor presentation7 May 2026 - Virtual annual meeting set for May 20, 2026, with key votes on directors, pay, and auditor.XRN
Proxy filing8 Apr 2026 - Annual meeting to vote on directors, compensation, equity plan, and auditor, with enhanced governance.XRN
Proxy filing8 Apr 2026 - Strategic shift to senior housing, strong NOI growth, and 2026 Core FFO guidance of $4.30–$4.45.XRN
Q4 202526 Feb 2026 - Q2 net loss from property sale, but occupancy and AFFO remain strong; acquisitions ongoing.XRN
Q2 20242 Feb 2026 - Q3 2024 featured resilient occupancy, major acquisitions, and new leasing amid lower earnings.XRN
Q3 202416 Jan 2026 - Q4 2024 saw strong net income, stable AFFO, and growth via acquisitions and a new joint venture.XRN
Q4 20242 Dec 2025 - Annual meeting to vote on directors, pay, auditor; 2024 saw acquisitions and ESG progress.XRN
Proxy Filing2 Dec 2025